Ampio Pharmaceuticals, Inc. (AMPE): Price and Financial Metrics

Ampio Pharmaceuticals, Inc. (AMPE): $0.50

0.25 (+105.00%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add AMPE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#285 of 357

in industry

AMPE Price/Volume Stats

Current price $0.50 52-week high $8.30
Prev. close $0.24 52-week low $0.14
Day low $0.30 Volume 7,800
Day high $0.51 Avg. volume 151,689
50-day MA $1.34 Dividend yield N/A
200-day MA $2.71 Market Cap 563.07K

AMPE Stock Price Chart Interactive Chart >


Ampio Pharmaceuticals, Inc. (AMPE) Company Bio


Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. has collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion. The company is headquartered in Englewood, Colorado.


AMPE Latest News Stream


Event/Time News Detail
Loading, please wait...

AMPE Latest Social Stream


Loading social stream, please wait...

View Full AMPE Social Stream

Latest AMPE News From Around the Web

Below are the latest news stories about AMPIO PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMPE as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!

William White on InvestorPlace | December 5, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning!

William White on InvestorPlace | December 1, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

William White on InvestorPlace | November 30, 2023

Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now

MIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting

Yahoo | November 1, 2023

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced that its CEO, Michael A. Martino will present in the Emerging Growth Conference on Thursday, November 2, 2023, at 1:10 pm ET.

Yahoo | October 31, 2023

Read More 'AMPE' Stories Here

AMPE Price Returns

1-mo -70.59%
3-mo -70.41%
6-mo -82.52%
1-year -88.49%
3-year -99.90%
5-year -99.71%
YTD -75.61%
2023 -54.48%
2022 -97.37%
2021 -64.15%
2020 172.73%
2019 47.59%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!